<DOC>
	<DOCNO>NCT00852345</DOCNO>
	<brief_summary>Clofazimine show effectiveness treatment leprosy many year . The World Health Organization National Hansen 's Disease Program consider clofazamine standard therapy treatment multibacillary leprosy . In recent year , availability drug become limited currently available research protocol consider `` investigational . '' Use Clofazamine patient present lepromatous leprosy necessary patient exhibit nerve involvement lesion resistant therapy . This drug use prospectively patient require treatment leprosy deem appropriate Kaiser Permanente Southern California physician .</brief_summary>
	<brief_title>Treatment Protocol Clofazamine Long Term Treatment Leprosy</brief_title>
	<detailed_description>Treatment protocol objective treat patient clofazamine meet inclusion criterion state .</detailed_description>
	<mesh_term>Leprosy</mesh_term>
	<mesh_term>Clofazimine</mesh_term>
	<criteria>Known suspected leprosy confirm skin biopsy and/or slit skin smear . Multibacillary leprosy ( lepromatous leprosy borderlinelepromatous ) . Paucibacillary leprosy ( borderline , borderline tuberculoid , indeterminate ) involvement cranial nerve active acute neuritis . Known suspected ENL ( erythema nodosum leprosum ) ( specific immune reaction painful skin nodule fever ) Known suspect dapsoneresistant leprosy relapse leprosy . Intolerance antileprosy antibiotic ( clofazamine substitute apart multidrug regimen ) Uncomplicated paucibacillary leprosy would otherwise treat dapsone rifampin . Known prior intolerance Clofazamine Any minor ( even parental consent ) Any fertile woman pregnant specific immune reaction painful skin rash fever )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>multibacillary leprosy</keyword>
	<keyword>leprosy</keyword>
	<keyword>clofazamine</keyword>
</DOC>